|
🐜
|
Skin sclerosis is only of limited value to identify SSc patients with severe manifestations--an analysis of a distinct patient subgroup of the German Systemic Sclerosis Network (DNSS) Register.
14 auth.
L. Hanitsch,
G. Burmester,
C. Witt,
N. Hunzelmann,
E. Genth,
T. Krieg,
W. Lehmacher,
Inga Melchers,
M. Meurer,
U. Müller-Ladner,
...
E. Schulze-Lohoff,
M. Becker,
C. Sunderkoetter,
G. Riemekasten
|
5 |
2008 |
5
🐜
|
|
🐜
|
OP0061 Update of Eular Recommendations for the Treatment of Systemic Sclerosis
12 auth.
O. Kowal-Bielecka,
J. Fransen,
J. Avouac,
M. Becker,
A. Kułak,
Y. Allanore,
...
O. Distler,
L. Czirják,
C. Denton,
K. Fligelstone,
J. Welling,
U. Mueller-Ladner
|
2 |
2015 |
2
🐜
|
|
🐜
|
POS0388 DEVELOPING A SCREENING TOOL FOR THE DETECTION OF INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS: THE ILD-RISC RISK SCORE
16 auth.
C. Bruni,
L. Tofani,
H. Fretheim,
S. Liem,
A. Velauthapillai,
H. Bjørkekjær,
I. Barua,
I. Galetti,
A. Garaiman,
M. Becker,
...
A. Hoffmann-Vold,
J. D. de Vries-Bouwstra,
M. Vonk,
J. Distler,
M. Matucci-Cerinic,
O. Distler
|
1 |
2022 |
1
🐜
|
|
🐜
|
OP0236 RISK FACTORS FOR SSc-ILD PROGRESSION USING THE NEW PPF GUIDELINE AND INBUILD PF-ILD CRITERIA
18 auth.
A. Hoffmann-Vold,
L. Petelytska,
H. Fretheim,
I. Barua,
M. Becker,
H. Bjørkekjær,
C. Brunborg,
C. Bruni,
P. Diep,
R. Dobrota,
...
M. Durheim,
M. Elhai,
S. Jordan,
E. Langballe,
Ø. Midtvedt,
C. Mihai,
Ø. Molberg,
O. Distler
|
0 |
2023 |
0
🐜
|
|
🐜
|
OP0003 DOES IMMUNOSUPPRESSIVE THERAPY IMPROVE GASTROINTESTINAL SYMPTOMS IN PATIENTS WITH SYSTEMIC SCLEROSIS?
12 auth.
L. Stamm,
A. Garaiman,
N. Zampatti,
M. Becker,
C. Bruni,
R. Dobrota,
...
M. Elhai,
S. Ismail,
S. Jordan,
A. Tatu,
O. Distler,
C. Mihai
|
0 |
2022 |
0
🐜
|
